Indoco Remedies
INDOCONSE

Indoco Remedies

₹202.410.99 (0.49%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
196.95
Today’s high
205.80
52 week low
162.19
52 week high
349.80
Open price
204.44
Previous close
201.42
Live volume
37,333
Lower circuit
161.93
Upper circuit
242.89

Fundamentals

Market Cap
₹1,851Cr
ROE
-11.28%
P/E Ratio(TTM)
-15.90
EPS(TTM)
-12.61
P/B Ratio
1.89
Dividend Yield
0.10%
Industry P/E
31.51
Book Value
106.15
Debt to Equity
1.02
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Indoco Remedies Limited is a pharmaceutical firm engaged in manufacturing and marketing formulations and Active Pharmaceutical Ingredients for domestic and international markets. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. To achieve this, it provides resources like financial aid and medicines to non-profit organizations, focusing on innovative and sustainable programs. In India, Indoco holds a strong position in various therapeutic segments, including Gastroenterology, Dentistry, Stomatology, and Respiratory care medicines. As part of its international strategy, the company acquired an 85% stake in Florida Pharmaceutical Product (FPP) in the USA to serve as its front-end arm. The company demonstrated robust performance, delivering 8% growth with revenues reaching ₹1762 crores for the year.;
MD/CEO
MS. ADITI PANANDIKAR
Founded in
1947
NSE symbol
INDOCO
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
58.90%
Retail And Others
21.85%
Mutual Funds
17.55%
Foreign Institutions
1.10%
Other Domestic Institutions
0.60%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹418.40
+3.40 (0.82%)
L
    H
    3,891.2443.425.34
    Innova CaptabINNOVACAP
    ₹689.35
    +8.55 (1.26%)
    L
      H
      3,883.2829.333.8
      Aarti DrugsAARTIDRUGS
      ₹355.10
      -2.55 (0.71%)
      L
        H
        3,261.9916.112.22
        ₹285.67
        +6.48 (2.32%)
        L
          H
          3,065.7464.0911.59
          Livesquawk
          Indoco Remedies' Q3 EBITDA rose to 315M INR from 120M YoY. EBITDA margin improved significantly to 7.1% from 2.9% YoY.
          Livesquawk
          Indoco Remedies faces GST inspection, with officials scrutinizing the company's office. The company is assisting authorities in ongoing investigations.
          2026
          3
          Feb
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date

          4
          Sep
          Dividend
          Ex date
          ₹0.20
          per share

          For each share you hold, you will receive ₹0.20
          Dividend amount₹0.20 per share
          Dividend TypeFinal
          Ex Date4 Sep ‘25
          Record Date4 Sep ‘25
          Announcement date22 May ‘25
          24
          Jul
          Quarterly Result
          Release date

          22
          May
          Dividend
          Announced
          ₹0.20
          per share

          For each share you hold, you will receive ₹0.20
          Dividend amount₹0.20 per share
          Dividend TypeFinal
          Ex Date4 Sep ‘25
          Record Date4 Sep ‘25
          Announcement date22 May ‘25
          2024

          19
          Sep
          Dividend
          Ex date
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date19 Sep ‘24
          Record Date19 Sep ‘24
          Announcement date16 May ‘24

          16
          May
          Dividend
          Announced
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date19 Sep ‘24
          Record Date19 Sep ‘24
          Announcement date16 May ‘24
          Events calendar
          View upcoming events in other stocks